Shaw AT, Peters S, Mok T, et al. Alectinib versus crizotinib in treatment-naive advanced ALK-positive non-small cell lung cancer (NSCLC): Primary results of the global phase III ALEX study. J Clin Oncol 35, 2017 (suppl; abstr LBA9008).
Ontlastingstest mogelijk alternatief voor colonoscopie tijdens controleafspraak
sep 2024 | Maag-darm-leveroncologie